Journal of Mid-life Health Journal of Mid-life Health
Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission | Subscribe | Advertise Users Online: 219  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 




 
 Table of Contents 
EDITORIAL
Year : 2022  |  Volume : 13  |  Issue : 3  |  Page : 199  

In this issue – Cancer is a concern


Dr. (Prof) (Hon) IMA and Director, Ahuja Health Care Services, Department of Obstetrics and Gynaecology, Faridabad, Haryana, India

Date of Submission12-Dec-2022
Date of Decision03-Jan-2023
Date of Acceptance10-Jan-2023
Date of Web Publication14-Jan-2023

Correspondence Address:
Maninder Ahuja
Dr. (Prof) (Hon) IMA and Director, Ahuja Health Care Services, Department of Obstetrics and Gynaecology, Faridabad, Haryana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jmh.jmh_235_22

Rights and Permissions

How to cite this article:
Ahuja M. In this issue – Cancer is a concern. J Mid-life Health 2022;13:199

How to cite this URL:
Ahuja M. In this issue – Cancer is a concern. J Mid-life Health [serial online] 2022 [cited 2023 Feb 1];13:199. Available from: https://www.jmidlifehealth.org/text.asp?2022/13/3/199/367759





Cancer breast and gynecological cancers are a huge burden for India and globally and their incidence is rising. We have to slow down this increase of cancer by prevention by judicial use of vaccines, changes in life style, early diagnosis by new biomarkers and early identification of rare cancers and combination of multiple cancers. Keeping in mind all these challenges, we have added related articles, original cases, short communication, and rare case presentations.

Ovarian cancer is one of the enigmatic cancers which is associated with high morbidity and mortality as it has nonspecific symptoms and no effective screening methods are available. Original article “Osteopontin as a tumor marker in Ovarian Cancer”. May fill the gap for research in the diagnostics of ovarian cancer. It would fill the gap for research in the diagnostics of ovarian cancer as presently used CA125 has its limitations.

PARP expression in breast cancer survivors is an upcoming research topic which should be definitely followed by those interested in breast cancer early diagnosis and management to reduce mortality, original study “Expression of PARP (poly ADP ribose polymerase) Protein in Breast Cancer.” JMH_132_22 gives a way forward research topic for our own Indian researchers.

Immunohistochemical markers have been highlighted for diagnosis and prognosis in Leiomyosarcoma in article “Leiomyosarcoma of the uterus and diagnostic challenges in diagnosing it on small biopsy”

Triple cancers are really a rare occurrence and enjoy reading about this case report and many more.

Let us all strive towards WHO goal of cervical cancer prevention by 2030 by vaccinating 90% girls by the age of 15 years, which now appears feasible as India has launched its quadrivalent vaccine by Serum Institute of India and that would be very cost effective and hopefully cervical cancer vaccination would be included in universal immunization program.

We all have to join hands for cervical cancer screening to achieve goal of screening 70% of women and appropriate treatment of 90% of those identified with cervical disease.

Please, enjoy reading all these articles.






 

Top
  
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article

 Article Access Statistics
    Viewed736    
    Printed4    
    Emailed0    
    PDF Downloaded55    
    Comments [Add]    

Recommend this journal